These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 16908997)

  • 21. Transgenic mouse models of prion diseases.
    Telling GC
    Methods Mol Biol; 2008; 459():249-63. PubMed ID: 18576160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current and future molecular diagnostics for prion diseases.
    Lehto MT; Peery HE; Cashman NR
    Expert Rev Mol Diagn; 2006 Jul; 6(4):597-611. PubMed ID: 16824033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular biology and pathogenesis of prion diseases.
    Prusiner SB
    Trends Biochem Sci; 1996 Dec; 21(12):482-7. PubMed ID: 9009832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
    Prusiner SB
    Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease.
    Jeffrey M; McGovern G; Sisó S; González L
    Acta Neuropathol; 2011 Jan; 121(1):113-34. PubMed ID: 20532540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The highways and byways of prion protein trafficking.
    Campana V; Sarnataro D; Zurzolo C
    Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.
    Collinge J; Sidle KC; Meads J; Ironside J; Hill AF
    Nature; 1996 Oct; 383(6602):685-90. PubMed ID: 8878476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics of prions.
    Prusiner SB; Scott MR
    Annu Rev Genet; 1997; 31():139-75. PubMed ID: 9442893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
    Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.
    Casalone C; Zanusso G; Acutis P; Ferrari S; Capucci L; Tagliavini F; Monaco S; Caramelli M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3065-70. PubMed ID: 14970340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prion protein interconversions.
    Caughey B
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):197-200; discussion 200-2. PubMed ID: 11260800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Slow virus disease: deciphering conflicting data on the transmissible spongiform encephalopathies (TSE) also called prion diseases.
    Bastian FO; Fermin CD
    Microsc Res Tech; 2005 Nov; 68(3-4):239-46. PubMed ID: 16276518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species-barrier phenomenon in prion transmissibility from a viewpoint of protein science.
    Hagiwara K; Hara H; Hanada K
    J Biochem; 2013 Feb; 153(2):139-45. PubMed ID: 23284000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into prion structure and toxicity.
    Harris DA; True HL
    Neuron; 2006 May; 50(3):353-7. PubMed ID: 16675391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prions: a mystery unravelled?
    Cavallo G; Lembo D; Cavallo R
    Riv Biol; 2010; 103(2-3):343-70. PubMed ID: 21384329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy.
    Vana K; Zuber C; Nikles D; Weiss S
    Cell Mol Neurobiol; 2007 Feb; 27(1):107-28. PubMed ID: 17151946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the 37 kDa laminin receptor precursor in the life cycle of prions.
    Rieger R; Lasmézas CI; Weiss S
    Transfus Clin Biol; 1999 Feb; 6(1):7-16. PubMed ID: 10188208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prion-like aggregates: infectious agents in human disease.
    Westermark GT; Westermark P
    Trends Mol Med; 2010 Nov; 16(11):501-7. PubMed ID: 20870462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms of prion pathogenesis.
    Aguzzi A; Sigurdson C; Heikenwaelder M
    Annu Rev Pathol; 2008; 3():11-40. PubMed ID: 18233951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.